As a fiercely independent person it kills me that I have to rely on caregivers for my most basic needs but it’s a reality I’ve had to learn to accept. Without these folks, I can’t function. My reality is that I require 24/7 care. My current caregiver lineup is tough. One of my longest shifts…
Category: Multiple Sclerosis Research
Its all in the Gut?
Tweet Myelin reactive T cells that have a receptors that target myelin have all they need to cause autoimmunity, all that is needed is for the cells to be activated to get into the CNS and cause disease. Here bacteriua in the smal, intesting of a twin with MS triggered disease and the bacteria from…
EBV and antibodies
Tweet A few years ago a couple of papers appearred that sent the MS World EBV mad and it awakened the idea that Epstein Barr Virus is in the causal pathway of MS. It was then suggested that antibodies to EBV cross react with glial proteins as the root cause…Whilst this process may be plausible…
Guest Voice: I’m grateful for my MS caregivers — my guardian angels
I’ve been blessed with extraordinary caregivers and people who have made my journey with multiple sclerosis (MS) profoundly different. When I was diagnosed, my world collapsed. Everything I knew about […] The post Guest Voice: I’m grateful for my MS caregivers — my guardian angels appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Here I Go Again
By Samuel Fitch Ten years! After about ten years away from the gym, I decided to walk back in the door. In that time, I’ve been living with multiple sclerosis (MS) and staying active, but not in the way most … Continue reading → Source: blog.mymsaa.org
Sativex MS spasticity spray now with CNX Therapeutics after sale
Sativex (nabiximols) — a cannabis-based oral spray used to ease spasticity in certain people with multiple sclerosis (MS) — has been acquired by CNX Therapeutics, which will now market the […] The post Sativex MS spasticity spray now with CNX Therapeutics after sale appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Cladribine v Gingo
Tweet Fingolimod was the first sphingosine-1-phosphate receptor modulator and in Europe is used second line after failure of a previous drug, siponimod is licenced in Europe for secondary progressive MS, ozanimod (not really used in UK) and ponseimod can be used first line for relapsing MS. They all target S1P1 receptor and in other countries…
New imaging tool detects damaged myelin across large brain areas
Researchers have developed a highly sensitive imaging technique that can detect damage to myelin, the fatty wrapping around nerve fibers that is damaged in multiple sclerosis (MS), in large areas […] The post New imaging tool detects damaged myelin across large brain areas appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
FDA approves use of robotic exoskeleton for MS rehabilitation
A robotic exoskeleton dubbed Atalante X, which allows people with severe mobility issues to stand upright for rehabilitation exercises, is now cleared by the U.S. Food and Drug Administration (FDA) for […] The post FDA approves use of robotic exoskeleton for MS rehabilitation appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
I’m learning what drains and recharges my MS social battery
I was probably never as outgoing or sociable as some people, but there was a time when I genuinely enjoyed most social activities. I was the guy who, by the […] The post I’m learning what drains and recharges my MS social battery appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com